Dependence of the microRNA profile in cutaneous melanoma on clinical and morphological characteristics of the tumor
- 作者: Komina A.1, Palkina N.1, Aksenenko M.1, Ruksha T.1
-
隶属关系:
- Krasnoyarsk State Medical University n.a. prof. V.F. Voyno-Yasenetsky
- 期: 卷 19, 编号 5 (2016)
- 页面: 266-272
- 栏目: Articles
- URL: https://journals.rcsi.science/1560-9588/article/view/37147
- DOI: https://doi.org/10.18821/1560-9588-2016-19-5-266-272
- ID: 37147
如何引用文章
全文:
详细
作者简介
A. Komina
Krasnoyarsk State Medical University n.a. prof. V.F. Voyno-YasenetskyKrasnoyarsk, 660022, Russian Federation
N. Palkina
Krasnoyarsk State Medical University n.a. prof. V.F. Voyno-YasenetskyKrasnoyarsk, 660022, Russian Federation
M. Aksenenko
Krasnoyarsk State Medical University n.a. prof. V.F. Voyno-YasenetskyKrasnoyarsk, 660022, Russian Federation
Tatyana Ruksha
Krasnoyarsk State Medical University n.a. prof. V.F. Voyno-Yasenetsky
Email: tatyana_ruksha@mail.ru
Dr. Sci. Med., Head of Department of pathophysiology Krasnoyarsk, 660022, Russian Federation
参考
- Имянитов Е.Н. Эпидемиология и биология опухолей кожи. Практическая онкология. 2012; 13(2): 61-8.
- Liu V., Mihm M.C. Pathology of malignant melanoma. Surg. Clin. North Am. 2003; 83(1): 31-60.
- Greenwald H.S., Friedman E.B., Osman I. Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model. Melanoma Res. 2012; 22(1): 1-8.
- Chan E., Patel R., Nallur S., Ratner E., Bacchiocchi A., Hoyt K., et al. MicroRNA signatures differentiate melanoma subtypes. Cell Cycle. 2011; 10(11): 1845-52.
- Joosse A., de Vries E., Eckel R., Nijsten T., Eggermont A.M., Hölzel D., et al. Gender differences in melanoma survival: female patients have a decreased risk of metastasis. J. Invest. Dermatol. 2011; 131(3): 719-26.
- Mervic L. Time course and pattern of metastasis of cutaneous melanoma differ between men and women. PLoS ONE. 2012; 7(3): e32955.
- Kaur A., Webster M.R., Marchbank K., Behera R., Ndoye A., Kugel C.H., et al. sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance. Nature. 2016; 532(7598): 250-4.
- Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2): 281-97.
- Ha T.Y. MicroRNAs in human diseases: from cancer to cardiovascular disease. Immune Netw. 2011; 11(3): 135-54.
- Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., et al. MicroRNA expression profiles classify human cancers. Nature. 2005; 435(7043): 834-8.
- Швецова Ю.И., Палкина Н.В., Аксененко М.Б., Рукша Т.Г. Изменения экспрессии микроРНК при меланоцитарных новообразованиях кожи. Российский журнал кожных и венерических болезней. 2015; 18(3): 6-9.
- Xu Y., Brenn T., Brown E.R., Doherty V., Melton D.W. Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors. Br. J. Cancer. 2012; 106(3): 553-61. doi: 10.1038/bjc.2011.568.
- Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B. 1995; 57(1): 289-300.
- Vlachos I.S., Kostoulas N., Vergoulis T., Georgakilas G., Reczko M., Maragkakis M., et al. DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res. 2012. http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=mirpath (дата обращения 04.07.2016).
- Сlark Jr. W.H., From L., Bernardino E.A., Mihm M.C. Histogenesis and biological behavior of primary human malignant melanomas of the skin. Cancer Res. 1969; 29(3): 705-27.
- Crowson A.N., Magro C.M., Mihm M.C. Prognosticators of melanoma, the melanoma report, and the sentinel lymph node. Modern Pathol. 2006; 19(Suppl. 2): S71-87.
- Mueller D.W., Rehli M., Bosserhoff A.K. miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma. J. Invest. Dermatol. 2009; 129(7): 1740-51.
- Jönsson G., Busch Ch., Knappskog S., Geisler J., Miletic H., Ringnér M., et al. Gene Expression Profiling-Based Identification of Molecular Subtypes in Stage IV Melanomas with Different Clinical Outcome. Clin. Cancer Res. 2010; 16(13): 3356-67.
- Scolyera R.A., Longa G.V., Thompsona J.F. Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care. Mol. Oncol. 2011; 5(2): 124-36.
- Smoller B.R. Histologic criteria for diagnosing primary cutaneous malignant melanoma. Modern Pathol. 2006: 19(Suppl. 2): S34-40.
- Barnhill R.L., Mihm M.C. The histopathology of cutaneous malignant melanoma.Seminars Diagn. Pathol. 1993; 10(1): 47-75.
- Poliseno L., Haimovic A., Segura M.F., Hanniford D., Christos P.J., Darvishian F., et al. Histology-specific microRNA alterations in melanoma. J. Invest. Dermatol. 2012; 132(7): 1860-8.
- Feinmesser M., Veltman V., Morgenstern S., Tobar A., Gutman H., Kaganovsky E., et al. Different patterns of expression of the erbB family of receptor tyrosine kinases in common nevi, dysplastic nevi, and primary malignant melanomas: an immunohistochemical study. Am. J. Dermatopathol. 2010; 32(7): 665-75.
- Van Belle P., Rodeck U., Nuamah I., Halpern A.C., Elder D.E. Melanoma-associated expression of transforming growth factor β isoforms. Am. J. Pathol. 1996; 148(6): 1887-94.
- Pardali K., Moustakas A. Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim. Biophys. Acta. 2007; 1775(1): 21-62.
- Caramuta S., Egyházi S., Rodolfo M., Witten D., Hansson J., Larsson C., et al. MicroRNA expression profiles associated with mutational status and survival in malignant melanoma. J. Invest. Dermatol. 2010; 130(8): 2062-70.
- Sand M., Skrygan M., Sand D., Georgas D., Gambichler Th., Hahn S.A., et al. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi. Cell Tissue Res. 2013; 351(1): 85-98.
- Segura M.F., Greenwald H.S., Hanniford D., Osman I., Hernando E. MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy. Carcinogenesis. 2012; 33(10): 1823-32.
- Lin R.L., Wang T.J., Joyce C.J., Mihm M.C., Murphy G.F., Lian C.G., Lin J.Y. Decreased tumor-infiltrating lymphocytes in nodular melanomas compared with matched super ficial spreading melanomas. Melanoma Res. 2016; 26(5): 524-7. doi: 10.1097/CMR.0000000000000253.
- Lauss M., Nsengimana J., Staaf J., Newton-Bishop J., Jönsson G. Consensus of melanoma gene expression subtypes converges on biological entities. J. Invest. Dermatol. 2016. pii: S0022-202X(16)31363-X. doi: 10.1016/j.jid.2016.05.119.